These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 11431698)

  • 1. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.
    Xu X; Qiao W; Linke SP; Cao L; Li WM; Furth PA; Harris CC; Deng CX
    Nat Genet; 2001 Jul; 28(3):266-71. PubMed ID: 11431698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.
    Xu X; Wagner KU; Larson D; Weaver Z; Li C; Ried T; Hennighausen L; Wynshaw-Boris A; Deng CX
    Nat Genet; 1999 May; 22(1):37-43. PubMed ID: 10319859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal lymphocyte development and thymic lymphoma formation in Brca1 exon-11-deficient mice.
    Bachelier R; Xu X; Wang X; Li W; Naramura M; Gu H; Deng CX
    Oncogene; 2003 Jan; 22(4):528-37. PubMed ID: 12555066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are Trp53 rescue of Brca1 embryonic lethality and Trp53/Brca1 breast cancer association related?
    McAllister KA; Wiseman RW
    Breast Cancer Res; 2002; 4(2):54-7. PubMed ID: 11879563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice.
    Brodie SG; Xu X; Qiao W; Li WM; Cao L; Deng CX
    Oncogene; 2001 Nov; 20(51):7514-23. PubMed ID: 11709723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
    Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
    Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist.
    Poole AJ; Li Y; Kim Y; Lin SC; Lee WH; Lee EY
    Science; 2006 Dec; 314(5804):1467-70. PubMed ID: 17138902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Brca1 and splice variant Brca1delta11 RNA levels in mouse mammary gland during normal development and tumorigenesis.
    Mixon M; Kittrell F; Medina D
    Oncogene; 2000 Nov; 19(46):5237-43. PubMed ID: 11077440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
    Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
    Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation.
    Deng CX; Scott F
    Oncogene; 2000 Feb; 19(8):1059-64. PubMed ID: 10713690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint.
    Wang RH; Yu H; Deng CX
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17108-13. PubMed ID: 15563594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 carries tumor suppressor activity distinct from that of p53 and p21.
    Randrianarison V; Marot D; Foray N; Cabannes J; Méret V; Connault E; Vitrat N; Opolon P; Perricaudet M; Feunteun J
    Cancer Gene Ther; 2001 Oct; 8(10):759-70. PubMed ID: 11687899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation.
    Hakem R; de la Pompa JL; Elia A; Potter J; Mak TW
    Nat Genet; 1997 Jul; 16(3):298-302. PubMed ID: 9207798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atm heterozygosity cooperates with loss of Brca1 to increase the severity of mammary gland cancer and reduce ductal branching.
    Bowen TJ; Yakushiji H; Montagna C; Jain S; Ried T; Wynshaw-Boris A
    Cancer Res; 2005 Oct; 65(19):8736-46. PubMed ID: 16204043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis.
    Brodie SG; Xu X; Li C; Kuo A; Leder P; Deng CX
    Oncogene; 2001 Mar; 20(12):1445-54. PubMed ID: 11313888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression.
    Bouwman P; Drost R; Klijn C; Pieterse M; van der Gulden H; Song JY; Szuhai K; Jonkers J
    J Pathol; 2011 May; 224(1):10-21. PubMed ID: 21404276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and analysis of Brca1 conditional knockout mice.
    Deng CX; Xu X
    Methods Mol Biol; 2004; 280():185-200. PubMed ID: 15187254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
    Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J
    Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice.
    Deng CX
    Mutat Res; 2001 Jun; 477(1-2):183-9. PubMed ID: 11376699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of p53 mutation in BRCA1-associated ovarian cancer.
    Rose SL; Buller RE
    Minerva Ginecol; 2002 Jun; 54(3):201-9. PubMed ID: 12063435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.